Ticker Details
Design Therapeutics, Inc.
IPO Date:	March 29, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$770.29M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.35 | 3.54%
Avg Daily Range (30 D):	$0.24 | 2.26%
Avg Daily Range (90 D):	$0.26 | 2.64%

Institutional Daily Volume
Avg Daily Volume:	.23M
Avg Daily Volume (30 D):	.24M
Avg Daily Volume (90 D):	.27M

Trade Size
Avg Trade Size (Sh.):	89
Avg Trade Size (Sh.) (30 D):	65
Avg Trade Size (Sh.) (90 D):	76

Institutional Trades
Total Institutional Trades:	306
Avg Institutional Trade:	$1.75M
Avg Institutional Trade (30 D):	$1.61M
Avg Institutional Trade (90 D):	$1.84M
Avg Institutional Trade Volume:	.16M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.33M
Avg Closing Trade (30 D):	$.94M
Avg Closing Trade (90 D):	$1.34M
Avg Closing Volume:	187.57K

News

Nov 26, 2025 @ 1:00 PM Design Therapeutics to Participate in Upcoming Inv... Source: Renee Leck

May 7, 2024 @ 10:30 AM Design Therapeutics to Participate in the 2024 RBC... Source: Design Therapeutics, Inc.

Mar 26, 2024 @ 11:37 AM Design Therapeutics And 2 Other Stocks Under $5 In... Source: Avi Kapoor

Mar 19, 2024 @ 8:01 PM Design Therapeutics Outlines Progress Across GeneT... Source: Design Therapeutics, Inc.

Mar 12, 2024 @ 10:30 AM Design Therapeutics to Webcast Fourth Quarter and ... Source: Design Therapeutics, Inc.

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-1.22	$-.27	$-1.22
Diluted EPS	$-1.22	$-.27	$-1.22
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-69.79M	$-16M	$-69.79M
Operating Income / Loss	$-79.47M	$-18.17M	$-79.47M
Cost of Revenue
Net Cash Flow	$-5.71M	$1.77M	$-5.71M
PE Ratio